| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3204379 | The Journal of Allergy and Clinical Immunology: In Practice | 2014 | 11 Pages |
Abstract
Despite multiple long-term controller medications, patients with severe or difficult-to-treat asthma on Steps 4/5/6 therapy present with significant clinical burden and risk of future asthma exacerbations.
Keywords
very poorly controlledNWCQOLMini-AQLQFVCExpert Panel Report 3VPCEPR-3OCsICSWPAINHLBIQuality of lifeUncontrolled asthmaLong-acting β2-agonistThe Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimensemergency departmentChronic obstructive pulmonary diseaseCOPDExacerbationstenorAsthma therapyasthma guidelinesLABAbody mass indexBMIforced vital capacityAnti-asthmatic agentsNational Heart, Lung, and Blood Instituteodds ratiooral corticosteroidInhaled corticosteroid
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
William J. MD, Tmirah PhD, David R. MS, Dave P. MS, Alejandro MD, Robert S. MD, PhD,